Zheng-huan LIU, Liang ZHOU, Zhi-hong LIU, Tao CHEN, Jia-qi LI, Kun-jie WANG, Hong LI, Yu-chun ZHU. Changes in Postoperative Blood Glucose and the Predictive Factors in Patients with Pheochromocytoma Complicated with Type 2 Diabetes[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(4): 342-345. doi: 10.3969/j.issn.1674-9081.2018.04.010
Citation: Zheng-huan LIU, Liang ZHOU, Zhi-hong LIU, Tao CHEN, Jia-qi LI, Kun-jie WANG, Hong LI, Yu-chun ZHU. Changes in Postoperative Blood Glucose and the Predictive Factors in Patients with Pheochromocytoma Complicated with Type 2 Diabetes[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(4): 342-345. doi: 10.3969/j.issn.1674-9081.2018.04.010

Changes in Postoperative Blood Glucose and the Predictive Factors in Patients with Pheochromocytoma Complicated with Type 2 Diabetes

doi: 10.3969/j.issn.1674-9081.2018.04.010
More Information
  • Corresponding author: ZHU Yu-chun Tel:028-49842471, E-mail:mmaalleee@126.com
  • Received Date: 2018-04-08
  • Publish Date: 2018-07-30
  •   Objective  We aimed to observe the changes in postoperative blood glucose of patients with pheochromocytoma complicated with type 2 diabetes and explore the potential predictive factors for the postoperative remission of diabetes.  Methods  Preoperative and follow-up information of patients with pheochromocytoma complicated with type 2 diabetes who underwent the surgery of radical resection in West China Hospital from January 2012 to December 2016 was retrospectively collected and analyzed. Analyzed variables included age, sex, body mass index (BMI), tumor diameter, preoperative blood catecholamine, preoperative and postoperative hypoglycemic regimen, and fasting blood glucose. Postoperative remission of diabetes was defined as discontinuing/reducing of hypoglycemic drugs or fasting blood glucose ≤ 6.1 mmol/L. According to with or without remission, the patients were divided into two groups:remission group and non-remission group. The predictive factors for remission were analyzed by single-variable Logistic regression analysis.  Results  Twenty-seven patients with pheochromocytoma complicated with type 2 diabetes who had full follow-up data were enrolled in this study, including 8 males and 19 females, aged (51±9)years old. The postoperative fasting blood glucose was significantly lower than the preoperative one[(5.14±1.37)mmol/L vs. (8.68±5.94)mmol/L, P < 0.01]. The overall remission rate of postoperative diabetes was 78% (21/27) and the non-remission rate was 22%(6/27). Single-variable Logistic regression analysis showed that age, sex, BMI, tumor diameter, and preoperative plasma catecholamine were unrelated to the postoperative remission of diabetes.  Conclusions  Radical resection for patients with pheochromocytoma complicated with type 2 diabetes could significantly improve diabetes after surgery. Age, sex, BMI, tumor diameter, and preoperative blood catecholamine are not the independent predictive factors for a postoperative remission of diabetes.
  • loading
  • [1] Davison AS, Jones DM, Ruthven S, et al. Clinical evaluation and treatment of phaeochromocytoma[J]. Ann Clin Biochem, 2018, 55: 34-48. doi:  10.1177/0004563217739931
    [2] Plouin PF, Amar L, Dekkers OM, et al. European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma[J]. Eur J Endocrinol, 2016, 174: G1-G10. http://smartsearch.nstl.gov.cn/paper_detail.html?id=b8fcdf4bab3878a9528c755a4ab7f49a
    [3] Fishbein L. Pheochromocytoma and paraganglioma: genetics, diagnosis, and treatment[J]. Hematol Oncol Clin North Am, 2016, 30: 135-150. doi:  10.1016/j.hoc.2015.09.006
    [4] Reisch N, Peczkowska M, Januszewicz A, et al. Pheochromocytoma: presentation, diagnosis and treatment[J]. J Hypertens, 2006, 24: 2331-2339. doi:  10.1097/01.hjh.0000251887.01885.54
    [5] Douma S, Petidis K, Kartali N, et al. Pheochromocytoma presenting as diabetic ketoacidosis[J]. J Diabetes Complications, 2008, 22: 295-296. doi:  10.1016/j.jdiacomp.2007.02.006
    [6] Martin JF, Martin LN, Yugar-Toledo JC, et al. Coronary emergency and diabetes as manifestations of pheochromocytoma[J]. Int J Cardiol, 2010, 139: e39-e41. doi:  10.1016/j.ijcard.2008.11.025
    [7] Komada H, Hirota Y, So A, et al. Insulin secretion and insulin sensitivity before and after surgical treatment of pheochromocytoma or paraganglioma[J]. J Clin Endocrinol Metab, 2017, 102: 3400-3405. doi:  10.1210/jc.2017-00357
    [8] Chen Y, Hodin RA, Pandolfi C, et al. Hypoglycemia after resection of pheochromocytoma[J]. Surgery, 2014, 156: 1404-1409. doi:  10.1016/j.surg.2014.08.020
    [9] La Batide-Alanore A, Chatellier G, Plouin PF. Diabetes as a marker of pheochromocytoma in hypertensive patients[J]. J Hypertens, 2003, 21: 1703-1707. doi:  10.1097/00004872-200309000-00020
    [10] Turnbull DM, Johnston DG, Alberti KG, et al. Hormonal and metabolic studies in a patient with a pheochromocytoma[J]. J Clin Endocrinol Metab, 1980, 51: 930-933. doi:  10.1210/jcem-51-4-930
    [11] Colwell JA. Inhibition of insulin secretion by catecholamines in pheochromocytoma[J]. Ann Intern Med, 1969, 71: 251-256. doi:  10.7326/0003-4819-71-2-251
    [12] Vance JE, Buchanan KD, O'Hara D, et al. Insulin and glucagon responses in subjects with pheochromocytoma: effect of alpha adrenergic blockade[J]. J Clin Endocrinol Metab, 1969, 29: 911-916. doi:  10.1210/jcem-29-7-911
    [13] Verberne AJ, Korim WS, Sabetghadam A, et al. Adrenaline: insights into its metabolic roles in hypoglycaemia and diabetes[J]. Br J Pharmacol, 2016, 173: 1425-1437. doi:  10.1111/bph.13458
    [14] Mesmar B, Poola-Kella S, Malek R. The physiology behind diabetes mellitus in patients with pheochromocytoma: a review of the literature[J]. Endocr Pract, 2017, 23: 999-1005. doi:  10.4158/EP171914.RA
    [15] Wiesner TD, Bluher M, Windgassen M, et al. Improvement of insulin sensitivity after adrenalectomy in patients with pheochromocytoma[J]. J Clin Endocrinol Metab, 2003, 88: 3632-3636. doi:  10.1210/jc.2003-030000
    [16] Cryer PE. Adrenaline: a physiological metabolic regulatory hormone in humans?[J]. Int J Obes Relat Metab Disord, 1993, 17 Suppl 3: S43-S46; discussion S68.
    [17] Rizza RA, Cryer PE, Haymond MW, et al. Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man[J]. J Clin Invest, 1980, 65: 682-689. doi:  10.1172/JCI109714
    [18] Beninato T, Kluijfhout WP, Drake FT, et al. Resection of pheochromocytoma improves diabetes mellitus in the majority of patients[J]. Ann Surg Oncol, 2017, 24: 1208-1213. doi:  10.1245/s10434-016-5701-6
    [19] 钟历勇.国际糖尿病联盟第19届世界大会会议纪要及新诊断指南精要解读[J].中国卒中杂志, 2007, 2: 66-67. doi:  10.3969/j.issn.1673-5765.2007.01.017
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(2)

    Article Metrics

    Article views (264) PDF downloads(92) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return